Cargando…

Cardiac Toxicity and Anthracyclines: Mechanism, Interventions, and the Trouble With Troponin

As cancer survivorship increases, clinicians need to become educated regarding the long-term effect of cancer treatments. Cancer therapeutics–related cardiac dysfunction (CTRCD) is one such sequela that contributes to significant morbidity and mortality. Unfortunately, screening and management pract...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Grace E., Wright, Phyllis P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520738/ https://www.ncbi.nlm.nih.gov/pubmed/33343984 http://dx.doi.org/10.6004/jadpro.2019.10.4.4

Ejemplares similares

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015)

Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based Chemotherapy
por: Tzolos, E., et al.
Publicado: (2020)

Radiotherapy and anthracyclines – cardiovascular toxicity
por: Mozdzanowska, Dagmara, et al.
Publicado: (2014)

Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse
por: Toldo, Stefano, et al.
Publicado: (2013)

Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
por: Liu, Jing, et al.
Publicado: (2022)

Selenium in the Prevention of Anthracycline-Induced Cardiac Toxicity in Children with Cancer
por: Tacyildiz, Nurdan, et al.
Publicado: (2012)

The Metabolic Pathway of Cardiac Troponins Release: Mechanisms and Diagnostic Role
por: Chaulin, Aleksey Michailovich
Publicado: (2022)

High-sensitive cardiac troponin T
por: Xu, Ru-Yi, et al.
Publicado: (2013)

Cardiac troponin and defining myocardial infarction
por: Kaier, Thomas E, et al.
Publicado: (2021)

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death
por: Antoniak, Silvio, et al.
Publicado: (2022)

Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
por: Huelsenbeck, J, et al.
Publicado: (2011)

Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
por: Vavrova, Anna, et al.
Publicado: (2013)

Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents
por: Seemann, Ingar, et al.
Publicado: (2013)

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity
por: Yang, Xinyu, et al.
Publicado: (2018)

Anthracycline‑induced delayed‑onset cardiac toxicity: A case report and literature review
por: Kong, Mowei, et al.
Publicado: (2023)

Biology of Cardiac Troponins: Emphasis on Metabolism
por: Chaulin, Aleksey M.
Publicado: (2022)

Anthracycline-induced toxicity affecting palmar and plantar skin.
por: Jones, A. P., et al.
Publicado: (1989)

Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation
por: Rahman, Atiar M, et al.
Publicado: (2007)

Cardiac Troponins Metabolism: From Biochemical Mechanisms to Clinical Practice (Literature Review)
por: Chaulin, Aleksey M.
Publicado: (2021)

Boys in Trouble
Publicado: (1939)

Cardiac Troponin Mutations and Restrictive Cardiomyopathy
por: Parvatiyar, Michelle S., et al.
Publicado: (2010)

High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine
por: Canale, Maria Laura, et al.
Publicado: (2018)

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study
por: Narayan, Hari K, et al.
Publicado: (2017)

Mycobacterium abscessus subsp abscessus lung disease: ‘trouble ahead, trouble behind…’
por: Griffith, David E.
Publicado: (2014)

COVID-19, cardiovascular diseases and cardiac troponins
por: Kim, Chan W, et al.
Publicado: (2021)

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs
por: Lawson, Haylie C., et al.
Publicado: (2021)

Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance
por: Aengevaeren, Vincent L., et al.
Publicado: (2021)

Dephosphorylation specificities of protein phosphatase for cardiac troponin I, troponin T, and sites within troponin T
por: Jideama, Nathan M., et al.
Publicado: (2006)

Cardiac Troponins as Biomarkers of Cardiac Myocytes Damage in Case of Arterial Hypertension: From Pathological Mechanisms to Predictive Significance
por: Chaulin, Aleksey Michailovich
Publicado: (2022)

HEART TROUBLE IN THE FAMILY
Publicado: (1970)

The Trouble with Medical Journals
por: Hadden, David R
Publicado: (2007)

Troubles of Children and Parents
Publicado: (1949)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Cardiac troponins: from myocardial infarction to chronic disease
por: Park, Kyung Chan, et al.
Publicado: (2017)

False-Positive Causes in Serum Cardiac Troponin Levels
por: Chaulin, Aleksey Michailovich
Publicado: (2022)

Prognostic Value of High-Sensitivity Cardiac Troponin in Women
por: Bisaccia, Giandomenico, et al.
Publicado: (2022)

Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity
por: Mahjoob, Mohammad P., et al.
Publicado: (2020)

The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity
por: Zhao, Jiazheng, et al.
Publicado: (2023)

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial
por: Henriksen, Peter A., et al.
Publicado: (2023)

The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity
por: Kotwinski, Paul, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ek39ucc1l02i4s923f19u4ja53